Showing results (181-190 of 206) with videos related to

Sort By:
Pageof 21
Journal of the National Cancer Institute|April 7, 2021
EGFR Amplification in Metastatic Colorectal CancerGiovanni Randon, Rona Yaeger, Jaclyn F Hechtman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2018
Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 BlockadeGiuseppe Lo Russo, Massimo Moro, Michele Sommariva, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 17, 2026
Adequacy criteria and reporting for prognostic and predictive profiling of biopsies from gastrointestinal neoplasia: A position paper from the Italian group of gastrointestinal pathologists, section of Italian society of anatomic pathology and cytology (GIPAD-SIAPeC-IAP)Paola Parente, Federica Grillo, Matilde Callegarin, et al.
Cancer Medicine|December 2, 2024
Molecular Characterization and Clinical Relevance of MGMT-Silenced Pancreatic CancerFederico Nichetti, Marco Silvestri, Luca Agnelli, et al.
Virchows Archiv : an International Journal of Pathology|January 3, 2024
Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectivesMichele Simbolo, Giovanni Centonze, Anastasios Gkountakos, et al.
International Journal of Cancer|June 20, 2022
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based studyMonica Niger, Federico Nichetti, Andrea Casadei-Gardini, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2021
Synaptophysin expression in <sup>V600EBRAF-</sup>mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosisMatteo Fassan, Massimo Milione, Giulia Maddalena, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2019
Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal CancerFilippo Pietrantonio, Riccardo Lobefaro, Maria Antista, et al.
Endocrine Pathology|May 13, 2022
Ampullary Neuroendocrine Neoplasms: Identification of Prognostic Factors in a Multicentric Series of 119 CasesAlessandro Vanoli, Oneda Grami, Catherine Klersy, et al.
Pageof 21